BioLase Dental Laser OKd for Soft-Tissue Uses

Medical device maker BioLase Technology Inc. in San Clemente said Wednesday that it has received federal clearance to market its dental laser for a number of other soft tissue procedures.

The company said in a news release that the additional procedures include the treatment of gum disease, a leading oral health problem.

BioLase stock gained 30 cents to close at $5.15 a share on Nasdaq's small-cap market. The stock has tripled in value this year.

Copyright © 2019, Los Angeles Times
EDITION: California | U.S. & World